Dexcom (DXCM)

Dexcom (DXCM) Stock Price & Analysis


DXCM Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$67.11 - $126.44
Previous Close$119.58
Average Volume (3M)2.27M
Market Cap
Enterprise Value$47.81B
Total Cash (Recent Filing)$623.20M
Total Debt (Recent Filing)$2.08B
Price to Earnings (P/E)169.8
Aug 02, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.70
Shares Outstanding387,635,623
10 Day Avg. Volume2,970,057
30 Day Avg. Volume2,270,219
Standard Deviation0.15
Financial Highlights & Ratios
Price to Book (P/B)22.30
Price to Sales (P/S)62.51
Price to Cash Flow (P/CF)73.10
P/FCF Ratio71.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue15.82
Enterprise Value/Gross Profit25.39
Enterprise Value/Ebitda85.58
Price Target Upside14.96% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Dexcom’s price range in the past 12 months?
Dexcom lowest stock price was $67.11 and its highest was $126.44 in the past 12 months.
    What is Dexcom’s market cap?
    Currently, no data Available
    When is Dexcom’s upcoming earnings report date?
    Dexcom’s upcoming earnings report date is Aug 02, 2023 which is in 61 days.
      How were Dexcom’s earnings last quarter?
      Dexcom released its earnings results on Apr 27, 2023. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.146 by $0.024.
        Is Dexcom overvalued?
        According to Wall Street analysts Dexcom’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Dexcom pay dividends?
          Dexcom does not currently pay dividends.
          What is Dexcom’s EPS estimate?
          Dexcom’s EPS estimate is $0.23.
            How many shares outstanding does Dexcom have?
            Dexcom has 387,635,620 shares outstanding.
              What happened to Dexcom’s price movement after its last earnings report?
              Dexcom reported an EPS of $0.17 in its last earnings report, beating expectations of $0.146. Following the earnings report the stock price went down -1.813%.
                Which hedge fund is a major shareholder of Dexcom?
                Among the largest hedge funds holding Dexcom’s share is Sands Capital Management LLC. It holds Dexcom’s shares valued at 2B.


                  Dexcom Stock Smart Score

                  The Dexcom stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description


                  California-based DexCom, Inc. is a medical device manufacturing company. The company designs, develops and focuses on commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes. Its products include DexCom G4 PLATINUM System, DexCom G5 Mobil, DexCom G6, and DexCom Share.


                  Top 5 ETFs holding DXCM

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Vanguard S&P 500 ETF
                  Invesco QQQ Trust
                  SPDR S&P 500 ETF Trust CDI
                  SPDR S&P 500 ETF Trust
                  Up to five ETFs with an Outperform Smart Score that hold DXCM. The ETFs are listed according to market value of DXCM within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Tandem Diabetes Care
                  Intuitive Surgical

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis